市場調査レポート
商品コード
1304586
コルポスコープの世界市場-2023年~2030年Global Colposcopes Market - 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
コルポスコープの世界市場-2023年~2030年 |
出版日: 2023年07月07日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
コルポスコープの世界市場は、2022年に6億米ドルに達し、2030年には9億米ドルに達し、有利な成長が予測されています。世界のコルポスコープ市場は予測期間(2023-2030年)にCAGR 5.7%を示すと予測されています。技術進歩の増加と新製品への投資の増加が、コルポスコープの需要動向を押し上げています。
コルポスコープの市場には、子宮頸がんや外陰がんなどの疾患の有無を確認する検査が含まれます。技術的に先進的な新製品の発売、子宮頸がん患者の増加がコルポスコープの世界市場を推進している主な要因です。
コルポスコープの市場範囲は、子宮頸がん検診、人間ドックなどのアプリケーションで構成されており、これがコルポスコープの市場シェアを高めています。コルポスコープの世界市場は、研究開発の増加や各国における新製品の承認などの要因により拡大しており、コルポスコープ市場の成長に明るい見通しをもたらしています。
女性の細胞診管理におけるコルポスコープの採用増加:がん診断市場の成長を牽引
浸潤がんや悪性度の高い子宮頸部前悪性病変の可能性が高い女性は、細胞診によって特定されます。細胞診に異常のある女性にとって、コルポスコピーのような診断検査は、異常を特定し、診断を確定し、最善の治療方針を決定するために不可欠です。
「see and treat」戦略は、コルポスコピーで疑われる高悪性度病変を有する女性に対し、組織学的確認を待たずに治療を行うものです。この戦略は、追跡調査不能率を減少させ、遠隔地で利用可能な限られた医療資源を有効に活用できることが実証されています。
インドの地域ベースの研究では、訓練された看護師がVIA陽性の女性に対してコルポスコピーを行い、異常病変が発見された場合、女性にはその日のうちに凍結療法が提供された(病変がアブレーションによる治療の条件を満たしていることが条件)。治癒率は、CIN 1(Cervical Intra-epithelial Neoplasia:子宮頸部上皮内新形成)が81.4%、CIN 2が71.4%、CIN 3が68.0%でした。対象となった女性のほぼ75%が、同診療で治療を受け入れました。
主な企業による研究開発と新製品の発売が増加し、メーカーに有利な機会を創出
人工知能(AI)を搭載したデジタル・モバイル・コルポスコープは、子宮頸がんの現在の標準治療にスクリーニングの選択肢を提供し、精度とスピードの大幅な向上を約束します。MobileODT社(イスラエル、テルアビブ)のEVAProは、子宮頸がん検診における最新の技術開発を導入し、患者と医師の相互作用を強化します。
最新のEVAProデジタルコルポスコープは、携帯可能で軽く、優れた画質と最先端のソフトウェア機能を備えています。医師は、この特別な組み合わせを使って、治療の全過程を記録、追跡、保存することができます。EVAProの画像は自発光であるため、鮮明な画像が得られます。画像解析では、異常動脈やその他のランドマークや病変を評価するためにグリーンフィルターが使用されます。子宮頸部の存在、照度、位置、焦点はすべてオートフォーカスを使用しながら各画像で評価されます。
画質は画像ガイド技術と機械学習(ML)を使って評価され、その画像が目視検査やコルポスコープ検査に適しているかどうかを医師に知らせます。EVAProは、機械学習(ML)と人工知能(AI)を使用して、広範囲な子宮頸がんスクリーニングを行う。治療の時点では、人工知能に基づくVisualCheckがコンピュータ支援診断ツールであり、EVAProデジタルコルポスコープを使用して異形成のリスクを評価します。
大腸内視鏡の代替品の入手が市場の成長を妨げます。
コルポスコープの世界需要は、大腸内視鏡の代替品の入手可能性などの問題によって抑制されています。以前の調査では、子宮頸部デジタル写真(CDP)が子宮頸部スクリーニングの代替技術として提案されました。
コルポスコピーの有望な代替法がCDPです。臨床におけるCDPの総合的な有用性は、さらなる研究によってよりよく理解されるであろう。コルポスコピーや子宮頸部写真のオンラインフォームも有用であろう。さらに、スマートフォンのカメラを使用することも、コルポスコピーの代用として有用です。
COVID-19影響分析
COVID-19の発生と世界の封鎖により、あらゆる業種の企業の財務安定性が影響を受けています。その結果、米国食品医薬品局(FDA)はCOVID-19健康緊急事態の期間中、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準(GCP)に従い、試験の完全性に対するリスクを低減するための一般的な考慮事項を含むガイドラインを発表しました。
ロシア・ウクライナ紛争影響分析
ロシアとウクライナの紛争は、この地域の主要な市場プレーヤーの数が少ないため、世界のコルポスコープ市場に与える影響は低いと推定されます。しかし、原材料の輸出入の影響は、予測期間中、世界のコルポスコープ市場の成長にほとんど影響を与えないと予測されます。
The global colposcopes market reached US$ 0.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 0.9 billion by 2030. The global colposcopes market is expected to exhibit a CAGR of 5.7% during the forecast period (2023-2030). The increasing technological advancements and the growing investments for novel products are driving up demand for colposcopes market trends.
The market for colposcopes includes tests that establish the existence of the cervical cancer or other diseases such as vulvar cancer and more. The launch of new technologically advanced products, and an increase in patients with cervical cancer are the main factors propelling the global market for colposcopes.
The colposcopes market scope comprises application as cervical cancer screening, physical examinations and others, which has increased the colposcopes market share. The global market for colposcopes is expanding as a result of factors including the increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the colposcopes market growth.
Women who are more likely to have invasive cancer or high-grade cervical premalignant lesions are identified by cytology. For women with abnormal cytology, a diagnostic test such a colposcopy is essential for localizing the abnormality, confirming the diagnosis, and determining the best course of treatment.
The "see and treat" strategy offers treatment to women who have high-grade lesions that are colposcopically suspected without waiting for histology confirmation. This strategy has been demonstrated to reduce the rates of follow-up loss and to effectively use the limited medical resources available in remote places.
In an Indian community-based study, trained nurses performed colposcopies on VIA-positive women, and if abnormal lesions were found, the women were offered cryotherapy treatment the same day (provided the lesion met the requirements for treatment by ablation). The cure results were 81.4% for women having CIN 1 (Cervical Intra-epithelial Neoplasia); 71.4% for CIN 2; and 68.0% for CIN 3. Almost 75 percent of eligible women accepted therapy at the same visit.
A digital mobile colposcope powered by artificial intelligence (AI) offers a screening option to the current standard treatment for cervical cancer, promising greatly improved accuracy and speed-delivery of results takes less than a minute. The EVAPro from MobileODT (Tel Aviv, Israel) introduces the most recent technological development in cervical cancer screening, enhancing the patient-physician interaction.
The latest EVAPro digital colposcope is portable and light, with outstanding image quality and cutting-edge software capabilities. Doctors can record, track, and store the full course of treatment using this special combination. The self-illuminating nature of EVAPro pictures makes for crisper image capturing. A green filter is used in image analysis to assess aberrant arteries and other landmarks or lesions. The existence, illumination, location, and focus of the cervix are all evaluated for each image while using autofocus.
Image quality can be assessed using image-guided technology and machine learning (ML), informing the doctor if the image would be appropriate for visual examination or colposcopic review. EVAPro uses machine learning (ML) and artificial intelligence (AI) for extensive cervical cancer screening. At the point of care, VisualCheck, based on artificial intelligence, computer-aided diagnostic tool, assesses the risk of dysplasia using the EVAPro digital colposcope.
Global demand for colposcopes is being restrained by issues like the availability of alternatives for colonoscopes. In earlier investigations, cervical digital photography (CDP) was previously proposed as an alternate cervical screening technique.
A promising substitute for colposcopy is CDP. The overall usefulness of CDP in clinical practice may be better understood with further study. Online forms for colposcopy or cervical photography may also be useful. Additionally, using a smartphone camera could be a useful substitute for colposcopy.
The financial stability of companies across all industries has been impacted by the COVID-19 outbreak and the global lockdown. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the duration of the COVID-19 health emergency that include general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.
The Russia-Ukraine conflict is estimated to have a low impact on the global colposcopes market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global colposcopes market growth over the forecast period.
The global colposcopes market is segmented based on type, product type, technology, application, end user and region.
One kind of cervical cancer test is a colposcopy. It is a test to examine the cervix more closely. The cervix is the vaginal opening into the womb. If a cervical screening reveals cell alterations brought on by specific forms of human papillomavirus (HPV), a colposcopy is frequently performed.
The procedure of screening allows for the early diagnosis of diseases. For those who have a cervix, screening for cervical cancer is an essential component of regular medical care. Finding precancerous alterations in cervical cells, which can be treated to stop cervical cancer from growing, is the aim of screening for the disease. During cervical screenings, cancer can occasionally be discovered. Usually, it is simpler to treat cervical cancer in its early stages.
Cervical cancer cells may develop from these altered cells. Colposcopy is still the preferred procedure in high-resource settings following a positive cervical cytology or human papillomavirus (HPV) test result. The quantity and location of biopsies, as well as the training and experience of the colposcopists, all have a significant impact on how well colposcopy can guide treatment.
Manufacturers have chances to expand their operations in this region because of the rising demand for colposcopes for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of colposcopes, which has increased the demand.
There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for research and development of novel products.
As new technologies for research and development are developed, the market will expand. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. People are becoming more aware of novel products and technologies, leading to the expansion of the market in this region. These factors are responsible for dominance of North America.
The major global players in the colposcopes market include: Olympus Corporation, CooperSurgical Inc., McKesson Medical-Surgical Inc., DYSIS Medical Inc., Gynex Corporation, Ecleris, Karl Kaps GmbH & Co. KG, Medgyn Products Inc., Delmont imaging and Seiler Instrument Inc. among others.
The global colposcopes market report would provide approximately 53 tables, 54 figures and 195 Pages.
Australia
LIST NOT EXHAUSTIVE